John Pagel is a hematology-oncology physician and senior vice president of clinical development and global head of hematology, Loxo@Lilly.
This article is sponsored by Loxo@Lilly, the oncology unit of Eli Lilly and Company.
In this special sponsored episode from Loxo@Lilly, I’m joined by Dr. John Pagel, senior vice president of clinical development and global head of hematology at Loxo@Lilly, to discuss blood cancer — what it is, advancements in research …
Get free updates delivered free to your inbox.
